The longitudinal association of lead with blood pressure

Barbara S. Glenn, Walter F. Stewart, Jonathan M Links, Andrew C. Todd, Brian S Schwartz

Research output: Contribution to journalArticle

Abstract

Background. Several investigators have reported an association of blood lead or bone lead with increased blood pressure and hypertension, but questions remain concerning whether these effects are acute or chronic in nature. Methods. In this longitudinal study, we evaluated the relation of lead, measured in blood and tibia, to changes in blood pressure between 1994 and 1998. We studied 496 current and former employees of a chemical-manufacturing facility in the eastern United States who had previous occupational exposure to inorganic and organic lead. Cohort members who provided three or four blood pressure measurements during the study were included. Results. Mean age at baseline was 55.8 years with a mean of 18 years since last occupational exposure to lead. Blood lead at baseline averaged 4-6 μg/dL (standard deviation [SD] = 2.6) or 0.22 μmole/Liter (SD = 0.13). Tibia lead at year three averaged 14.7-μg/gm (SD = 9.4) bone mineral. Change in systolic blood pressure during the study was associated with lead dose, with an average annual increase of 0.64 mmHg (standard error [SE] = 0.25), 0.73 mmHg (SE = 0.26), and 0.61 mmHg (SE = 0.27) for every standard deviation increase in blood lead at baseline, tibia lead at year three, or peak past tibia lead, respectively. Conclusions. The results support an etiologic role for lead in the elevation of systolic blood pressure among adult males and are consistent with both acute and chronic modes of action.

Original languageEnglish (US)
Pages (from-to)30-36
Number of pages7
JournalEpidemiology
Volume14
Issue number1
DOIs
StatePublished - Jan 2003

Fingerprint

Blood Pressure
Tibia
Occupational Exposure
Bone and Bones
Lead
Minerals
Longitudinal Studies
Research Personnel
Hypertension

Keywords

  • Blood pressure
  • Chemical-manufacturing workers
  • Hypertension
  • Lead
  • X-ray fluorescence (XRF)

ASJC Scopus subject areas

  • Epidemiology

Cite this

The longitudinal association of lead with blood pressure. / Glenn, Barbara S.; Stewart, Walter F.; Links, Jonathan M; Todd, Andrew C.; Schwartz, Brian S.

In: Epidemiology, Vol. 14, No. 1, 01.2003, p. 30-36.

Research output: Contribution to journalArticle

Glenn, Barbara S. ; Stewart, Walter F. ; Links, Jonathan M ; Todd, Andrew C. ; Schwartz, Brian S. / The longitudinal association of lead with blood pressure. In: Epidemiology. 2003 ; Vol. 14, No. 1. pp. 30-36.
@article{f5db868af9664d97a83034197836c012,
title = "The longitudinal association of lead with blood pressure",
abstract = "Background. Several investigators have reported an association of blood lead or bone lead with increased blood pressure and hypertension, but questions remain concerning whether these effects are acute or chronic in nature. Methods. In this longitudinal study, we evaluated the relation of lead, measured in blood and tibia, to changes in blood pressure between 1994 and 1998. We studied 496 current and former employees of a chemical-manufacturing facility in the eastern United States who had previous occupational exposure to inorganic and organic lead. Cohort members who provided three or four blood pressure measurements during the study were included. Results. Mean age at baseline was 55.8 years with a mean of 18 years since last occupational exposure to lead. Blood lead at baseline averaged 4-6 μg/dL (standard deviation [SD] = 2.6) or 0.22 μmole/Liter (SD = 0.13). Tibia lead at year three averaged 14.7-μg/gm (SD = 9.4) bone mineral. Change in systolic blood pressure during the study was associated with lead dose, with an average annual increase of 0.64 mmHg (standard error [SE] = 0.25), 0.73 mmHg (SE = 0.26), and 0.61 mmHg (SE = 0.27) for every standard deviation increase in blood lead at baseline, tibia lead at year three, or peak past tibia lead, respectively. Conclusions. The results support an etiologic role for lead in the elevation of systolic blood pressure among adult males and are consistent with both acute and chronic modes of action.",
keywords = "Blood pressure, Chemical-manufacturing workers, Hypertension, Lead, X-ray fluorescence (XRF)",
author = "Glenn, {Barbara S.} and Stewart, {Walter F.} and Links, {Jonathan M} and Todd, {Andrew C.} and Schwartz, {Brian S}",
year = "2003",
month = "1",
doi = "10.1097/00001648-200301000-00011",
language = "English (US)",
volume = "14",
pages = "30--36",
journal = "Epidemiology",
issn = "1044-3983",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The longitudinal association of lead with blood pressure

AU - Glenn, Barbara S.

AU - Stewart, Walter F.

AU - Links, Jonathan M

AU - Todd, Andrew C.

AU - Schwartz, Brian S

PY - 2003/1

Y1 - 2003/1

N2 - Background. Several investigators have reported an association of blood lead or bone lead with increased blood pressure and hypertension, but questions remain concerning whether these effects are acute or chronic in nature. Methods. In this longitudinal study, we evaluated the relation of lead, measured in blood and tibia, to changes in blood pressure between 1994 and 1998. We studied 496 current and former employees of a chemical-manufacturing facility in the eastern United States who had previous occupational exposure to inorganic and organic lead. Cohort members who provided three or four blood pressure measurements during the study were included. Results. Mean age at baseline was 55.8 years with a mean of 18 years since last occupational exposure to lead. Blood lead at baseline averaged 4-6 μg/dL (standard deviation [SD] = 2.6) or 0.22 μmole/Liter (SD = 0.13). Tibia lead at year three averaged 14.7-μg/gm (SD = 9.4) bone mineral. Change in systolic blood pressure during the study was associated with lead dose, with an average annual increase of 0.64 mmHg (standard error [SE] = 0.25), 0.73 mmHg (SE = 0.26), and 0.61 mmHg (SE = 0.27) for every standard deviation increase in blood lead at baseline, tibia lead at year three, or peak past tibia lead, respectively. Conclusions. The results support an etiologic role for lead in the elevation of systolic blood pressure among adult males and are consistent with both acute and chronic modes of action.

AB - Background. Several investigators have reported an association of blood lead or bone lead with increased blood pressure and hypertension, but questions remain concerning whether these effects are acute or chronic in nature. Methods. In this longitudinal study, we evaluated the relation of lead, measured in blood and tibia, to changes in blood pressure between 1994 and 1998. We studied 496 current and former employees of a chemical-manufacturing facility in the eastern United States who had previous occupational exposure to inorganic and organic lead. Cohort members who provided three or four blood pressure measurements during the study were included. Results. Mean age at baseline was 55.8 years with a mean of 18 years since last occupational exposure to lead. Blood lead at baseline averaged 4-6 μg/dL (standard deviation [SD] = 2.6) or 0.22 μmole/Liter (SD = 0.13). Tibia lead at year three averaged 14.7-μg/gm (SD = 9.4) bone mineral. Change in systolic blood pressure during the study was associated with lead dose, with an average annual increase of 0.64 mmHg (standard error [SE] = 0.25), 0.73 mmHg (SE = 0.26), and 0.61 mmHg (SE = 0.27) for every standard deviation increase in blood lead at baseline, tibia lead at year three, or peak past tibia lead, respectively. Conclusions. The results support an etiologic role for lead in the elevation of systolic blood pressure among adult males and are consistent with both acute and chronic modes of action.

KW - Blood pressure

KW - Chemical-manufacturing workers

KW - Hypertension

KW - Lead

KW - X-ray fluorescence (XRF)

UR - http://www.scopus.com/inward/record.url?scp=0037208958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037208958&partnerID=8YFLogxK

U2 - 10.1097/00001648-200301000-00011

DO - 10.1097/00001648-200301000-00011

M3 - Article

VL - 14

SP - 30

EP - 36

JO - Epidemiology

JF - Epidemiology

SN - 1044-3983

IS - 1

ER -